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AntinociceptiveAbstract One diterpenoid, horminone 1, two ﬂavonoid glycosides, apigenin-7-O-(600-E-p-
coumaroyl)-b-D-glucopyranoside 2, isoscutellarein-7-O-(600 0-O-acetyl-b-D-allopyranosyl-(1ﬁ 2)-b-
D-glucopyranoside) 3, were isolated from n-butanolic extract of the aerial parts of Stachys mialhesi
de Noe´ (BESM). Their structures were established on the basis of physical and spectroscopic anal-
ysis, and by comparison with the literature data. Antioxidant activity of this extract and the com-
pound 3 was evaluated by the use of the Electron Spin Resonance method in order to visualize the
inhibition of the DPPH radical. In this study, we also investigated the anti-inﬂammatory, anti-ulcer
and antinociceptive activities of the BESM in experimental animal models at different doses. Our
results showed that the BESM showed a strongest antioxidant activity. It decreased acetic acid
induced writhing times; inhibited carrageenan-induced hind paw edema. All of these results sug-
gested that the BESM possesses signiﬁcant antioxidant, antinociceptive and anti-inﬂammatory
activities.
ª 2011 Production and hosting by Elsevier B.V. on behalf of King Saud University. This is an open access
article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/3.0/).1. Introduction
The genus Stachys (Lamiaceae) contains about 200–300 spe-
cies in the world (Rechinger and Hedge, 1982) and is consid-
ered to be one of the largest genera of this family. In
Algeria, this genus is represented by 14 species including the
S192 S. Laggoune et al.endemic species Stachys mialhesi de Noe´ (Quezel and Santa,
1962).
To our knowledge,S. mialhesi de Noe´ has not been the sub-
ject of any study. However, pharmacological studies conﬁrmed
that extracts or components of plants belonging to the
genus Stachys exert signiﬁcant antibacterial (Skaltsa et al.,
1999), anti-inﬂammatory (Zinchenko et al., 1981), antitoxic
(Zinchenko et al., 1981), anti-nephritic (Hayashi et al.,
1994a,b), antihepatitis (Savchenko and Khvorostinka, 1978),
anti-anoxia effects (Yamahara et al., 1990), effect on hyaluron-
idase activity (Takeda et al., 1985) and hypotensive activity
(Taked et al., 1997). Some species of this genus are used in folk
medicine, especially S. palustris L. and S. sylvatica L. (Wound
wort), as disinfectant, antispasmodic and for treatment of
wounds (Gruenwald et al., 2000). In Iran, the aerial parts of
S. inﬂata Benth are used to treat infection, asthma, rheumatic
and other inﬂammatory disorders (Maleki et al., 2001). S.
lavandulifolia Vahl was used as an anxiolytic and sedative
(Amin, 1991).
We report here for the ﬁrst time the isolation and identiﬁ-
cation of secondary metabolites of the n-butanolic extract ob-
tained from the endemic species S. mialhesi de Noe´ aerial
parts. The anti-inﬂammatory, antinociceptive and antioxidant
activities of this plant are also investigated.2. Experimental
2.1. General procedures
1H and 13CNMR spectra were obtained on a Bruker model
300, AMX-400 and AMX-600 spectrometers with standard
pulse sequences operating at 300, 400 and 600 MHz in 1H
and 125, 150 MHz in 13C NMR. DMSO-d6 and CDCl3 are
used as solvents. EIMS and HRE-IMS were taken on a Micro-
mass model Autospec (70 eV) spectrometer. Column chroma-
tography (CC) was carried out on polyamid, and prep. TLC
on silica gel 60 PF254 + 366 plates (20 · 20 cm, 1 mm). Indo-
methacin (Sigma, USA), Acetylsalicylic acid (El Vasr Co.),
Carrageenan (BDH, England), Tween 80 (Sigma, Germany),
saline (Sigma, Germany). All the chemicals and reagents used
were of the highest grade of purity.2.2. Plant material
Aerial parts of S. mialhesi de Noe´ were collected on April 2005
at Djebel El-Ouahch Constantine (North Eastern Algerian).
The voucher specimen was identiﬁed by Professor Ge´rard De
Be´lair (University Badji-Mokhtar, Annaba) and was deposited
at the Muse´e botanique de la Ville d’Angers (France) under the
reference MBAng2005.10.2.3. Preparation of the extract
Air-dried and powdered aerial parts (1 kg) of S. mialhesi were
extracted with 70%MeOH. The residue was dissolved in water
and extracted with petroleum ether, dichloromethane, ethyl
acetate and n-BuOH, successively.
Each solvent free extract was dissolved in Tween 80 (7%
aqueous solution) as vehicle and biologically tested in different
dose levels. The studied biological activities of the tested ex-tract were compared with the reference standard as well as
the controls injected with 0.2 ml vehicle (7% Tween 80).2.4. Isolation of chemical constituents
The n-butanolic extract (10 g) has been chromatographed over
polyamid column and eluted with a gradient of toluene/meth-
anol with increasing polarity. Fraction F4, obtained from tol-
uene 92% (50 mg) was subjected to another silica gel column
chromatography and eluted with a gradient of dichlorme-
thane/methanol with increasing polarity. Fraction F4.4
(38 mg) was further subjected to preparative silica gel TLC
and eluted with dichloromethane/methanol (80:20) leading to
compound 1 (7 mg) which was identiﬁed as horminone, re-
ported for the ﬁrst time from Stachys genus and compound
2 (25 mg) which was identiﬁed as apigenin-7-b-D-(600-E-p-
coumaroyl)-glucopyranoside, and isoscutellarein-7-O-(600 0-O-
acetyl-b-D-allopyranosyl-(1ﬁ 2)-b-D-glucopyranoside) (3). The
latter precipitated in all fractions starting from toluene 90%
from which 3g of this compound is gathered.
2.5. Animals
Animal studies were conducted in accordance with the interna-
tionally accepted principles for laboratory animal use; Animals
were obtained from the Animals house colony of the National
Research Center, Cairo, Egypt.
Adult albino mice of both sex weighing (20–25 g) and adult
male albino rats weighing (120–150 g) were used for determi-
nation of the medium lethal dose (LD50), analgesic activity
and carrageenan-induced edema, ulcerogenic effect, respec-
tively. The animals were kept under normal laboratory condi-
tions of humidity, temperature (25 ± 1 C) and light
(12 h day:12 h night), and allowed free access to food and
water.
2.6. Evaluation of antioxidant activity
2.6.1. Analyses of phenolic compounds
Total phenol concentration was determined according to
the Folin–Ciocalteu method, using pyrogallol as a standard.
The absorbance was measured at 760 nm on a Uvikon 930
UV/vis spectrophotometer (Kontron instruments) and the
results were expressed as pyrogallol equivalents in g per
100 g of the dry material (Kujala et al., 2000).
2.6.2. 1,1-Diphenyl-2-picrylhydrazyl (DPPH) scavenging test
The antioxidant activity of BESM and compound (3) was as-
sessed on the basis of the scavenging activity of the stable
1,1-diphenyl-2-picrylhydrazyl (DPPH, from Sigma) free radi-
cal (Fatimi et al., 1993) using ESR (Electron Spin Resonance)
spectroscopy (Yamaguchi et al., 2000). Reaction mixtures con-
tained 100 ml test samples and 100 ml DPPH ethanolic solu-
tion (5 · 104 M). Inhibition ratio was determined by
comparison with a water-treated control group. ESR spectra
were obtained with a Bruker ESP300E spectrometer using mi-
cro-sampling pipettes at room temperature under the following
conditions: modulation frequency, 100 kHz; modulation
amplitude, 0.197 mT; scanning ﬁeld, 349.7 mT; receiver gain,
1.25 · 105; sweep time, 11 s; microwave power, 4 mW; micro-
wave frequency, 9.78 GHz. All spectra were recorded at
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centage was calculated by using the double integral of the sig-
nal (Eq. 1):
Inhibition ratio ¼ ref-extract
ref-bg
ð1Þ
where ref is the reference signal (DPPH+ water), extract is the
test signal, bg is the background signal. The data were the
means of ﬁve measurements.
2.7. Determination of the medium lethal dose (LD50)
For acute toxicity study, groups of ﬁve mice of both sexes (20–
25 g) were used, one group injected with the corresponding
volume 0.2 ml of the vehicle (Tween 80) and served as control
and the tested extract were orally administered in doses rang-
ing from 1000 to 10,000 mg/kg body weight. Animals were ob-
served and the mortality rates were recorded within the ﬁrst
24 h after extract administration. The LD50 was determined
according to Behrens and Kerber method (Behrens and
Kerber, 1935).
2.8. Evaluation of analgesic activity
2.8.1. Acetic acid induced writhing method
Groups of six mice of both sex (20–25 g) were used, one group
injected with the corresponding volume 0.1 ml of the vehicle
(saline) and served as control and the tested extract and refer-
ence drug were orally (p.o.) administered in doses ranging 5–
10 g/kg body weight 30 min before of a intraperitoneal (i.p.)
freshly prepared acetic acid (2% W/v in saline; pH 2.7;
10 ml/kg body weight) injection.
The animals were then placed immediately to individual in
a transparent plastic box. The number of writhes, a response
consisting of contraction of an abdominal wall, pelvic rotation
followed by hind limb extension, was counted during continu-
ous observation for 20 min beginning from 5 min after the ace-
tic acid injection and the percentage inhibition of writhing was
expressed. Acetylsalicylic acid (200 mg/kg, p.o) was used as a
reference drug against which the test extracts were compared
(Koster et al., 1959).
2.9. Evaluation of anti-inﬂammatory activity
2.9.1. Carrageenan-induced rat paw edema
The inhibitory activity of the studied extract on carrageenan-
induced rat’s paw edema was investigated according to the
method of Winter et al. (1962).
Adult male albino rats (110–130 g), with free access to
water but had been fasted overnight (18 h), received a subplan-
tar injection of 0.05 ml of 1% suspension of carrageenan in sal-
ine into the plantar tissue in the right hind paw. An equal
volume of saline was injected into the other hind paw and
served as control.
Data are expressed as a percentage increase in paw thick-
ness and the differences between treated animals and the con-
trol group were expressed at the same time point after
carrageenan injection. In this part of the study, rats were allo-
cated randomly to one of six groups each were orally dosed
with the test extract, one hour before carrageenan challenge:
(a) controls (saline, n= 6); (b) n-butanolic extract (5000 mg/kg, n= 6); (c) indomethacin (5 mg/kg, n= 6). Orally, injec-
tion of extract or indomethacin was performed 60 min before
carrageenan injection.
Four hours after extract administration, the animals were
decapitated and the paw was rapidly excised. The average
weight of edema was estimated for the treated as well as the
control group. The percentage inhibition of weight of edema
was also evaluated. Indomethacin was employed as standard
against which the test extracts were compared.
2.10. Ulcerogenic effect
Groups of adult male albino rats of six animals each (110–
150 g) were fasted overnight, and orally given the tested extract
at a dose level of 5 g/kg body weight, for four consecutive
days. Four hours following the last dosing, animals were sac-
riﬁced, their stomach were removed, opened along the greater
curvature, and the numbers of ulcers were assessed by adopt-
ing the method of Correl et al. (1979).
2.11. Data and statistical analysis
Data were expressed as mean ± s.e.m, statistical comparisons
between different groups were made by analysis of variance
(ANOVA) followed by multiple comparison tests (Post hoc
Dunnett’s). Differences with p< 0.05 between experimental
groups and control animals were considered statistically signif-
icant (Norusis, SPSS INC).3. Results and discussion
3.1. Characterization of isolated compounds
The n-butanolic extract (BESM), obtained after maceration of
the aerial parts of S. mialhesi with MeOH/H2O (7:3) followed
by ﬁltration, concentration and successive liquid–liquid extrac-
tions using petroleum ether, dicholoromethane, ethyl acetate
and n-butanol, successively, led to the isolation of one diterp-
enoid, Horminone (1), and two ﬂavonoids glycosides, apige-
nin-7-O-(600-E-p-coumaroyl)-b-D-glucopyranoside (2) and
isoscutellarein-7-O-(600 0-O-acetyl-b-D-allopyranosyl-(1ﬁ 2)-b-
D-glucopyranoside) (3) (Fig. 1). These compounds were
identiﬁed by the use of 1H NMR and 13C NMR, DEPT, and
2D NMR experiments, COSY, HMQC, HMBC in addition
with UV spectroscopy.
3.1.1. Horminone (1): Yellow crystals
1H NMR (300 MHz, DMSO-d6) d: 0. 89 (3H, s, Me-19), 0.97
(3H, s, Me-18), 1.15 (m, H-1a), 1.18 (d, J= 7.0 Hz, Me-16),
1.20 (3H, s, Me-20), 1.21 (d, J= 7.0 Hz, Me-17), 1.18–1.41
(m, H-3a, b), 1.46 (m, H-2a), 1.48 (m, H-5), 1.52 (dd,
J= 12.6 Hz, J= 4.5 Hz, H-6b), 1.65 (m, H-2b), 1.89 (d,
J= 12.6 Hz, H-6a), 2.65 (ddd, J= 4.0, 4.0, 12.0 Hz, H-1b),
3.01 (s, 7-OH), 3.15 (septet, J= 7.1 Hz, H-15), 4.65 (dd,
J= 4.5 Hz, J= 1.5 Hz, H-7), 7.28 (s, OH-12). 13C NMR
(DMSO-d6, 125 MHz) d: 34.8 (C-1), 17.8 (C-2), 40.0 (C-3),
38.1 (C-4), 44.7 (C-5), 24.8 (C-6), 62.2 (C-7), 142.2 (C-8),
146.8 (C-9), 32.0 (C-10), 182.8 (C-11), 150.0 (C-12), 123.2
(C-13), 188.1 (C-14), 22.9 (C-15), 18.7 (C-16), 18.8 (C-17),
32.1 (C-18), 20.7 (C-19), 17.3 (C-20) EISM: m/z 332 [M]+
(Jonathan et al., 1989).
Figure 1 Chemical structures of compounds 1–3.
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(2)
Yellow powder. UV (kmax in MeOH): gives bands at 317,
268 nm for band I and II, addition of NaOH; 370 and 262,
NaOAc; 317 and 268, H3BO3; 300, 317, 385 and 268, AlCl3;
322, 380, 421 and 278, 298 while HCl; 323, 377 and 278, 298.
1H NMR (600 MHz, DMSO-d6) d: 6.48 (1H, d, J= 2.0 Hz,
H-6), 6.82 (1H, d, J= 2.0 Hz, H-8), 6.85 (s, H-3), 6.93 (2H,
d, J= 9.0 Hz, H-30/50), 7.95 (2H, d, J= 8.4 Hz, H-20/60),
12.95 (1H, s, OH-5). 3.85 (1H, td, J= 1.8 H, J= 7.2 Hz, H-
500), 4.16 (1H, dd, J= 12.0, 7.2 Hz, H-600a), 4.46 (1H, dd,
J= 1.8, 11.4 Hz, H-600b), 5.17 (1H, d, J= 7.8 Hz, H-100),
6.34 (1H, d, J= 16.2 Hz, H-a), 6.67 (2H, d, J= 9.0 Hz, H-
300 0/500 0), 7.38 (2H, d, J= 8.4 Hz, H-200 0/600 0), 7.50 (1H, d,
J= 16.2 Hz, H-b), 13C NMR (DMSO-d6, 150 MHz) d: 164.6
(C-2), 103.4 (C-3), 182.4 (C-4), 161.8 (C-5), 99.8 (C-6), 163.1
(C-7), 95.1 (C-8), 157.3 (C-9), 105.8 (C-10), 121.4 (C-10),
128.9 (C-20/C-60), 116.4 (C-30/C-50), 161.1 (C-40), 99.9 (C-100),
73.3 (C-200), 76.6 (C-300), 70.3 (C-400), 74.2 (C-500), 63.8 (C-600),
114.1 (C-a), 145.3 (C-b), 125.3 (C-100 0), 130.6 (C-200 0/C-600 0),
116.1 (C-300 0/C-500 0), 160.2 (C-400 0), 166.9 (C‚O), HRESIMS:
m/z 601.1328 (calcd for C30H26O12 Na) (Itokawa et al.,
1981). Acid hydrolysis of 2 produced the aglycone moiety
and D-glucose.
3.1.3. Isoscutellarein-7-O-(600 0-O-acetyl-b-D-allopyranosyl-
(1ﬁ 2)-b-D-glucopyranoside) (3)
Yellow powder. UV (kmax in MeOH): gives bands at 308, 326,
277 nm for band I and II, addition of NaOH; 384 and 275,
NaOAc; 309, 388 and 276, H3BO3; 309, 327 and 276, AlCl3;
322, 345, 421 and 283 while HCl; 322, 343, 420 and 283. 1H
NMR (DMSO-d6, 400 MHz) d: 1.81 (3H, s, OCH3), 4.87(1H, d, J= 8.0 Hz, H-100 0), 5.01 (1H, d, J= 7.5 Hz, H-100),
6.63 (1H, s, H-6), 6.76 (1H, s, H-3), 6.89 (2H, d, J= 8.8 Hz
H-30/H-50), 7.95 (2H, d, J= 8.8 Hz H-20/H-60), 12.29 (1H, s,
OH-5). 13C NMR (DMSO-d6, 125 MHz) d: 164.1 (C-2),
102.6 (C-3), 182.3 (C-4), 152.2 (C-5), 99.4 (C-6), 150.5 (C-7),
127.5 (C-8), 143.7 (C-9), 105.5 (C-10), 121.1 (C-10), 128.6 (C-
20/C-60), 115.9 (C-30/C-50), 161.3 (C-40), 100.0 (C-100), 82.5 (C-
200), 77.1 (C-300), 69.2 (C-400), 75.5 (C-500), 60.5 (C-600), 102.5
(C-100 0), 70.7 (C-200 0), 77.1 (C-300 0), 66.8 (C-400 0), 71.5 (C-500 0),
63.5 (C-600 0), 20.4 (CH3 acetyl), 170.3 (C‚O), HRESIMS: m/
z 675.1547 (calcd for C29H32O17 Na) (Lenherr and Mabry,
1987). Acid hydrolysis of 3 produced isoscutellarein, D-glucose
and D-allose.3.2. Antioxidant activity and phenol composition
The antioxidant and free radical scavenging powers of pheno-
lic compounds have been extensively studied for the past
10 years. The roles of OH groups and p electron delocalization
in ﬂavonoids have been largely discussed (Rice-Evans et al.,
1996).
Many plants which contain ﬂavonoids are known to pos-
sess good antioxidant activities by comparison with reference
molecules such as vitamin E.
In this study, it was ﬁrst speculated that S. mialhesi de Noe´
might be a source of natural antioxidants. The performed test
conﬁrmed the ability of the BESM and compound (3) to scav-
enge DPPH radical.
The idea that this activity was due to the presence of phe-
nolic compounds led us to investigate the phenolic composi-
tion of the BESM.
Figure 2 (a) IC50 of BESM. (b) IC50 of compound (3).
Table 1 Phenolic composition and IC50 DPPH of the BESM
and compound (3).
Phenolic composition
(g/100 g equiv. pyrogallol)
IC50 DPPH (mg/ml)
BESM 17.9 ± 0.1 0.047 ± 0.0048
Compound (3) 0.066 ± 0.002
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50% inhibition (IC50) of BESM and compound (3). By com-
parison, the value of IC50 of vitamin E was, under the same
experimental conditions, 0.025 mg/ml. Quercetin IC50 values
were used as a reference (Rice-Evans et al., 1996). In the
DPPH test, quercetin IC50 was 0.012 mg/ml. The extract
IC50 (0.047 mg/ml) was the result of a mixture of molecules,
with or without antioxidant activity. The IC50 value
0.066 mg/ml was the result of a pure molecule (3) (Table 1).
3.3. Acute toxicity
The result of the acute toxicity for BESM showed that the
tested extract assayed up to 10 g/kg did not prove to be toxic
since it did not induce mortality or toxic manifestations in mice
up to 24 h after administration.
3.4. Antinociceptive effect
The results (Table 2) demonstrate that the BESM, when
administered orally at different doses (10,000, 5000 mg/kg),
caused an inhibition of the writhing response induced by aceticacid (i.p.) (p< 0.05). The signiﬁcant protective effect was
dose-dependent. The percentage inhibitions of writhing pro-
duced by the extract were 77.11, 58.22, respectively, for each
dose. The standard drug acetylsalicylic acid (200 mg/kg),
exhibited about 72.99 inhibitions.
Thus, the results obtained from the antinociceptive effect of
the BESM revealed the existence of a peripheral analgesic
property (Lee et al., 1994).
The acetic acid induced abdominal constriction method elu-
cidated peripheral activity. The BESM was shown to possess
antinociceptive activity at the tested doses. This was evident
in all the nociceptive models, which indicates that it possesses
Table 2 Effect of the BESM on acetic acid induced abdominal constriction in mice.
Animal groups Dose (mg/kg) Number of writhing
X0 ± s.e.mb
% Protection
Control – 24.33a ± 1.86 –
Acetylsalicylic acid 200 6.57* ± 0.87 72.99
n-Butanol extract 5000 10.17*,a ± 0.87 58.22
n-Butanol extract 10,000 5.57* ± 1.23 77.11
* Signiﬁcantly different from control value at p< 0.05.
a Signiﬁcantly different from acetylsalicylic acid (200 mg/kg) value at p< 0.05.
b Each value represents the mean (number of writhing) ± s.e. of the number of animals in each group (n= 6).
Table 3 Anti-inﬂammatory activity of the BESM in Carrageenan induced rat’s paw edema.
Animal groups Dose (mg/kg) % increase in weight of paw edema (g)
X0 ± s.e.mb
% Protection
Control – 71.94a ± 3.28 –
Indomethacin 5 11.97* ± 3.23 83.36
BESM 5000 34.51*,a ± 4.4 52.03
The results demonstrate that the BESM can play a signiﬁcant role in the inhibition of pain and inﬂammatory processes.
* Signiﬁcantly different from control value at p< 0.05.
a Signiﬁcantly different from indomethacin (5 mg/kg) value at p< 0.05.
b Each value represents the mean (increase in rat’s paw edema) ± s.e. of the number of animals in each group (n= 6).
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et al., 2004).
3.5. Effects of the BESM on carrageenan-induced paw edema
Oral injections of BESM (5000 mg/kg) decreased the carra-
geenan-induced inﬂammation signiﬁcantly (p< 0.05).
The results presented in Table 3 indicated that BESM
exhibited a signiﬁcant anti-inﬂammatory activity, where it sig-
niﬁcantly decreased the weight of edema: 52% induced by car-
rageenan in the rat’s paw (Table 3) using indomethacin (5 mg/
kg) as a reference drug.
Carrageenan-induced inﬂammation is a suitable method
for evaluation of the anti-inﬂammatory effects of the agents
(Winter et al., 1962). The inﬂammation consists of two phases.
It appears that the early phase is related to the production of
histamine, 5-hydroxytryptamin, bradykinins and cyclooxygen-
ase products, while the delayed phase has been linked to neu-
trophil inﬁltration, as well as to the continuing of the
production of arachidonic metabolites (Salvemini et al.,
1996; Boughton-Smith et al., 1999). BESM was capable of
attenuating both early and delayed phases of carrageenan-in-
duced inﬂammation. The extract in the higher dose failed to in-
hibit the paw edema associated with the second phase.
Compared to a standard non-steroidal anti-inﬂammatory
drug (NSAID), indometacin, the BESM decreased licking re-
sponse similar to high doses of indomethacin.
Flavonoids were considered to be the active components
responsible for the biological actions of the genus Stachys
(El-Ansari et al., 1991).
Anti-ulcer activity. The BESM was found to be devoid of
ulcerogenicity at the tested dose level (5000 mg/kg body
weight) compared to indomethacin (5 mg/kg body weight, ul-
cer index 21.6) used as reference drug (Makhlouf et al., 2002).In the n-butanol-induced stress gastric ulcer test in rats, it
was shown that the tested extract produced signiﬁcant dose-
dependent gastroprotective activity.
In conclusion, this study has shown that the BESM exhibited
signiﬁcant antioxidant, antinociceptive and anti-inﬂammatory
effects in laboratory animals.We can also conclude thatS. mial-
hesi de Noe´ is a natural source of isoscutellarein 7-O-(200-O-600 0-
O-acetyl-b-D-allopyranosyl-b-D-glucopyranosideAcknowledgments
The authors are grateful to the ANDRS and DG-RSDT/MES-
RS for the ﬁnancial support.
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